# A Study of Mircera for the Maintenance Treatment of Participants With Chronic Renal Anemia

> **NCT00550680** · PHASE3 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 208 (actual)

## Conditions studied

- Chronic Renal Anemia

## Interventions

- **DRUG:** Methoxy polyethylene glycol-epoetin beta

## Key facts

- **NCT ID:** NCT00550680
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 208 (ACTUAL)
- **Last updated:** 2016-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00550680

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00550680, "A Study of Mircera for the Maintenance Treatment of Participants With Chronic Renal Anemia". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00550680. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*